measles/mumps/rubella/varicella vaccine (live-attenuated) (Shanghai Institute of Biological Products)

N/A

Report date: 2025/01/26 17:17:42

Base Information

Drug Namemeasles/mumps/rubella/varicella vaccine (live-attenuated) (Shanghai Institute of Biological Products)
Drug Alias NameN/A
ClassificationVaccines > Development/production technology > Live attenuated vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsRubivirus InfectionsMumpsMorbillivirus Infections +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShanghai Institute of Biological Products Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Institute of Biological Products Co Ltd
Inactive CompaniesN/A
Active IndicationsRubivirus InfectionsMumpsMorbillivirus Infections +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A